Navigation Links
UltraShape(R) Commences Pivotal Study for First Non-Invasive Fat Reduction and Body Contouring Device Using Non-Thermal Selective Focused Ultrasound
Date:6/12/2008

YOQNEAM, Israel and SAN RAMON, California, June 12 /PRNewswire/ --

- Study Will Evaluate Safety and Effectiveness of Contour Plus(TM) Device

UltraShape(R), a global leader in non-invasive fat reduction and body contouring, today announced the commencement of its pivotal IDE (Investigational Device Exemption) study to evaluate Contour Plus(TM), the first non-invasive device for fat reduction and body contouring using non-thermal selective focused ultrasound.

The next generation Contour Plus is based on the Contour I platform, which is available outside the U.S. and has been shown in pre-clinical and clinical studies to target and selectively break down fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact.

Contour Plus incorporates advanced technology to reduce treatment time and is intended to provide a non-invasive, fat reduction and body contouring solution for both men and women.

"This is a ground-breaking study for the aesthetics field. The Contour Plus has the potential to be the first system to create a durable, measurable fat thickness reduction," said Jeffery M. Kenkel, M.D., F.A.C.S., lead investigator, Vice Chairman and Professor of Plastic Surgery at the University of Texas Southwestern Medical Center, and Chairman, UltraShape Medical Advisory Board. "I believe the UltraShape study will demonstrate the ability of Contour Plus to selectively target and break down fat cells through non-thermal, acoustic effects."

"This IDE study signifies a landmark milestone for our company and huge potential for UltraShape to lead an industry breakthrough and become the first non-invasive treatment for measurable fat reduction for the purpose of body contouring in the United States," said Rodger Stewart, President and Chief Executive Officer of UltraShape. "We are excited to begin the pivotal trial and move closer to the commercialization of UltraShape in the Un
'/>"/>

SOURCE UltraShape Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Exelixis Commences Public Offering of Common Stock
3. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
4. American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program
5. Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program
6. Cytopia Commences Phase II Cancer Drug Study
7. Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
8. SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
9. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
10. China Sky One Medical, Inc. Commences Trading on the American Stock Exchange
11. Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... The Annual Thematic issue of Experimental Biology ... is devoted to "The biology and medicine of ... participating in the Microphysiological Systems Program directed by ... of the National Institutes of Health (NIH) and ... The Defense Advanced Research Projects Agency (DARPA) and ...
(Date:9/2/2014)... 2014 For the eighth consecutive year, ... network services company, has been named one of the ... 5000 list highlights America's fastest growing companies. CentraComm has ... list inception in 2007. , Landing on the list ... over the past three years. , “We are exceptionally ...
(Date:9/2/2014)... Farmington, New York (PRWEB) September 02, 2014 ... Millworks is making it easy to create a consistent look ... the physical structure, to the floor you walk on and ... shop for all custom reclaimed wood designs. , “We’re ... customers to our product line. It saves time, adds consistency, ...
(Date:9/2/2014)... York (PRWEB) September 02, 2014 - ... defined as a class of diagnostic test that analyzes ... The nucleic acids and proteins that belong to individual ... therapy, health condition, or risk of developing a specific ... better known as (MDx) evaluating the new class of ...
(Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... on addressing the non-adherence epidemic with a simple, ... effects including increasing life span and reducing health care ... patented, groundbreaking prescription pill bottle cap that puts control ... allows an individual to easily set the next date ...
Breaking Medicine News(10 mins):Health News:Microphysiological systems will revolutionize experimental biology and medicine 2Health News:Microphysiological systems will revolutionize experimental biology and medicine 3Health News:CentraComm Named to Inc. 5000 for 8th Consecutive Year 2Health News:Pioneer Millworks Now Offering Products Beyond Reclaimed Wood Flooring 2Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 2Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 3Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 4Health News:REMIND-A-CAP™ , A New York City Based Company Invents Groundbreaking Prescription Cap to Curb Non-Adherence 2
... Help Families Organize, Navigate the,Complicated Medical, Education Needs ... Today, the Autism,Society of America (ASA) and MeadWestvaco,s ... to design an autism-themed Cambridge,Planner in honor of ... go on sale at 1,000 Wal-Mart stores nationwide ...
... a type of acute leukemia may occur in part because ... over-activity of genes important to the disease. , , The research ... mutation called NPM1, an alteration seen in about one-third of ... for treating the disease and should improve the understanding of ...
... Association,of Homes and Services for the Aging (AAHSA) ... the Medicare SNF payment system, rationalize,payments and better ... The research presented at today,s MedPAC meeting shows ... payments would shift and - among other,things - ...
... inflammation helps blunt cardiovascular threats, study suggests , , THURSDAY, ... rheumatoid arthritis may also be reducing their risk of ... , People with rheumatoid arthritis (RA), which causes pain, ... face a greater risk of cardiovascular disease, because it ...
... Pharmaceuticals,Inc. (Nasdaq: TRBN ), today announced that it plans ... Dec. 31, 2007, after the,close of market on March 13, ... 2008, at 2 p.m. PDT (5 p.m. EDT)., Third-Quarter ... March,13, 2008, Participants are invited to call 877-545-1491 or ...
... HOUSTON, March 6 Carriage Services, Inc.,(NYSE: CSV ) ... 2008 Outlook that was previously announced on February 4, 2008.,Highlight ... operations for 2006 were as follows:, -- Revenues ... of $150.3 million for 2006. -- Total Field EBITDA ...
Cached Medicine News:Health News:MeadWestvaco and Autism Society of America Launch 2008 ASA Autism Awareness Cambridge Planner 2Health News:MeadWestvaco and Autism Society of America Launch 2008 ASA Autism Awareness Cambridge Planner 3Health News:Low micro-RNA level linked to high gene activity in AML 2Health News:Rheumatoid Arthritis Drugs May Lower Heart Attack, Stroke Risk 2Health News:Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call 2Health News:Carriage Services Reports 2007 Full Year Results 2Health News:Carriage Services Reports 2007 Full Year Results 3Health News:Carriage Services Reports 2007 Full Year Results 4Health News:Carriage Services Reports 2007 Full Year Results 5Health News:Carriage Services Reports 2007 Full Year Results 6Health News:Carriage Services Reports 2007 Full Year Results 7Health News:Carriage Services Reports 2007 Full Year Results 8Health News:Carriage Services Reports 2007 Full Year Results 9Health News:Carriage Services Reports 2007 Full Year Results 10Health News:Carriage Services Reports 2007 Full Year Results 11Health News:Carriage Services Reports 2007 Full Year Results 12Health News:Carriage Services Reports 2007 Full Year Results 13Health News:Carriage Services Reports 2007 Full Year Results 14Health News:Carriage Services Reports 2007 Full Year Results 15Health News:Carriage Services Reports 2007 Full Year Results 16Health News:Carriage Services Reports 2007 Full Year Results 17Health News:Carriage Services Reports 2007 Full Year Results 18Health News:Carriage Services Reports 2007 Full Year Results 19Health News:Carriage Services Reports 2007 Full Year Results 20Health News:Carriage Services Reports 2007 Full Year Results 21Health News:Carriage Services Reports 2007 Full Year Results 22Health News:Carriage Services Reports 2007 Full Year Results 23Health News:Carriage Services Reports 2007 Full Year Results 24Health News:Carriage Services Reports 2007 Full Year Results 25Health News:Carriage Services Reports 2007 Full Year Results 26Health News:Carriage Services Reports 2007 Full Year Results 27Health News:Carriage Services Reports 2007 Full Year Results 28Health News:Carriage Services Reports 2007 Full Year Results 29
(Date:9/2/2014)... -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ... Drew Young has joined the company as Senior ... will be responsible for leading the strategic direction of ... Bringing more than 20 years of experience ... pharmaceutical and biotech companies, Mr. Young comes to EMD ...
(Date:9/2/2014)... , Sept. 2, 2014  Boston Scientific Corporation (NYSE: ... announced agreement to purchase the Interventional business of ... Boston Scientific to offer physicians and healthcare systems ... challenging vascular conditions. The addition of ... technologies supports the Boston Scientific strategy to provide ...
(Date:9/2/2014)... Mass. , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... President and Chief Executive Officer, will present at the Morgan ... , New York on Tuesday, ... Interested parties are invited to listen to the live audio ... website at www.hologic.com/investors-overview . An archive of the presentation ...
Breaking Medicine Technology:EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 2Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 3Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 4Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG 5
... Conference: February 13-16, 2012 ,Exposition: February ... Organizers of the Medical Design and Manufacturing (MD&M) West ... be held at the Anaheim Convention Center, February 13-16, ... event in the United States dedicated to medical design ...
... N.C., Jan. 20, 2012  As the pace of ... has become challenging for the biopharma industry to ... messages. Consumers, key opinion leaders, payers ... and biotech companies reach out to with marketing ...
Cached Medicine Technology:MD&M West 2012 to Feature Twenty Collocated Conferences 2Utilizing Marketing Innovations to Engage with Customer Groups that are Key to the Pharmaceutical Industry 2
Neomycin and Polymyxin B Sulfates and Hydrocortisone otic suspension, USP is a sterile antibacterial and anti-inflammatory suspension for otic use....
Prednisolone Acetate ophthalmic suspension USP, 1% is an adrenocortical steroid product prepared as a sterile ophthalmic suspension....
... A sophisticated research tool that allows ... area which is being stimulated. Besides it ... the examiner to switch between the pupil ... computer screen. This system is especially suited ...
The only air-based esthesiometer with a database of normal sensation on the cornea. May have application to the measurement of normal-tension glaucoma....
Medicine Products: